feed,title,long_url,short_url
Benzinga,Aprea Therapeutics Stock Drops On FDA Clinical Hold On Eprenetapopt Myeloid Malignancy Trials,https://benzinga.com/general/biotech/21/08/22370358/aprea-therapeutics-stock-drops-on-fda-clinical-hold-on-eprenetapopt-myeloid-malignancy-trials,https://j.mp/3lyYTZH
Benzinga,"Certara To Buy Compliance Software Provider For $310; Q2 Earnings Beat Expectations, Raises FY21 Guidance",https://benzinga.com/news/earnings/21/08/22370229/certara-to-buy-compliance-software-provider-for-310-q2-earnings-beat-expectations-raises-fy21-guida,https://j.mp/3xxB32x
